Micro-RNA-204 Participates in TMPRSS2/ERG Regulation and Androgen Receptor Reprogramming in Prostate Cancer

Krassimira Todorova1, Metodi V Metodiev2, Gergana Metodieva2

  • 1Institute of Biology and Immunology of Reproduction "Acad. Kiril Bratanov", Laboratory of Reproductive OMICs Technologies, Bulgarian Academy of Sciences, 73 Tsarigradsko shosse blvd, 1113, Sofia, Bulgaria.

Hormones & Cancer
|January 5, 2017
PubMed

Insights

MicroRNA-204 (miR-204) regulates TMPRSS2/ERG oncofusion and androgen receptor (AR) signaling in prostate cancer. It acts as a tumor suppressor by inhibiting TMPRSS2/ERG and upregulating AR, with implications for cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer progression involves genome instability and rearrangements like TMPRSS2/ERG fusions.
  • MicroRNAs (miRNAs) can exhibit dual roles, acting as tumor suppressors or oncogenes.
  • Previous studies indicated miR-204 has context-dependent effects in ERG fusion-positive cancers.

Purpose of the Study:

  • To investigate the role of miR-204 in modulating TMPRSS2/ERG and androgen receptor (AR) signaling in prostate cancer.
  • To elucidate the regulatory mechanisms of miR-204 on TMPRSS2/ERG expression and AR signaling.
  • To develop a novel method for detecting TMPRSS2/ERG protein products.

Main Methods:

  • Proximity-based ligation assay for TMPRSS2/ERG protein detection.
  • Analysis of DNA methylation, promoter activity, and gene expression.
  • Proteomics to study miR-204's role in AR reprogramming.
  • Patient serum analysis for fusion transcripts and protein products.

Main Results:

  • miR-204 negatively regulates TMPRSS2/ERG oncofusion via DNA methylation of the TMPRSS2 promoter.
  • RUNX2 and ETS1 promote TMPRSS2/ERG expression and promoter hypomethylation.
  • miR-204 upregulates AR by direct promoter hypomethylation, potentiated by ERG fusion, RUNX2, and ETS1.
  • miR-204 exhibits a dual role in AR reprogramming, promoting androgen-responsive and AR target genes.

Conclusions:

  • miR-204 acts as a negative regulator of TMPRSS2/ERG oncofusion in prostate cancer.
  • miR-204 plays a significant role in modulating AR signaling, influencing AR target genes and co-regulatory molecules.
  • miR-204's methylation-dependent regulation involves chromatin remodeling and DNA methylation pathways.
  • miR-204 fine-tunes AR function during preserved AR sensitivity, crucial for ERG-fusion translocation.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K